Targeted Hypoglossal Neurostimulation Study #2 (THN2)
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Sponsor: ImThera Medical, Inc.
This NA trial investigates Respiration Disorders and Signs and Symptoms, Respiratory and is currently completed. ImThera Medical, Inc. leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Phase: PHASE2_PHASE3 → NA
▶ Show 3 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2_PHASE3
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ImThera Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .